Seelos Therapeutics Inc (SEEL)

[mean gene]

What I do not understand is why are they doing this if is not in the best interest of the company and the shareholders. The higher the pps the more money they make in options and in incentives. I don't believe that Denner invested in this company to not make money and Pascoe took the job for a quick buck and move on. I know what they done in hindsight does not make sense, but I have to believe they are trying to make this work. The market treated this company like a one trick pony with the failure of Fispemifene when the golden egg has always been Vitaros. The game is not over and I don't believe that Denner and Pascoe are out to ruin the shareholders and company at their expense.